Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and Alzheimer's Disease Status- The REMIND Study

NCT05406778 is registered in ClinicalTrials.gov with Spark Neuro Inc. as lead sponsor.

NCT NCT05406778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and Alzheimer's Disease Status- The REMIND Study
Lead sponsor
Spark Neuro Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 18, 2022
Completion date
January 19, 2024
Enrollment
185 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment